These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 10709412
1. Treatment and prevention of sudden cardiac death--what have we learnt from randomised clinical trials? Kam RM, Teo WS, Koh TH, Lim YL. Singapore Med J; 1999 Nov; 40(11):707-10. PubMed ID: 10709412 [Abstract] [Full Text] [Related]
2. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators. Ho AT, Pai SM, Timothy P, Pai RG. Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799 [Abstract] [Full Text] [Related]
3. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death. Lau EW, Griffith MJ, Pathmanathan RK, Ng GA, Clune MM, Cooper J, Marshall HJ, Forsey PR, Stafford PJ, Gray RG, Skehan JD, Garratt CJ. Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648 [Abstract] [Full Text] [Related]
4. [The patient at risk of sudden death:value of drug therapy]. Bonhorst D. Rev Port Cardiol; 2000 Feb; 19(2):233-9. PubMed ID: 10763353 [Abstract] [Full Text] [Related]
9. Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy. Droogan C, Patel C, Yan GX, Kowey PR. Heart Fail Clin; 2011 Apr; 7(2):195-205, viii. PubMed ID: 21439498 [Abstract] [Full Text] [Related]
10. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs]. Haverkamp W, Borggrefe M, Block M, Böcker D, Breithardt G. Z Kardiol; 1996 Apr; 85 Suppl 6():97-106. PubMed ID: 9064989 [Abstract] [Full Text] [Related]
18. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated]. Alboni P. Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849 [Abstract] [Full Text] [Related]